A Phase 1, Single-Center, Single-Blind, Placebo and Propofol Controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous (IV) Infusion Doses of ABP-700
Phase of Trial: Phase I
Latest Information Update: 14 Jun 2016
At a glance
- Drugs MDCO 700 (Primary) ; Propofol
- Indications Anaesthesia
- Focus Adverse reactions
- Sponsors Annovation BioPharma
- 14 Jun 2016 Status changed from recruiting to completed, according to The Medicines Company media release.
- 01 Jun 2015 Status changed from not yet recruiting to recruiting according to The Medicines Company media release.
- 06 Sep 2014 New trial record